Scholar Rock Q4 net loss widens; secures new debt facility
Overview
Biopharmaceutical firm's Q4 2025 net loss widened to $91 mln, no revenue recorded
Company secured up to $550 mln in non-dilutive capital for apitegromab commercialization
Apitegromab U.S. and European launches expected in 2026, pending regulatory approvals
Outlook
Scholar Rock expects U.S. launch of apitegromab in 2026 after FDA approval
EMA decision on apitegromab MAA anticipated mid-2026, European launch in H2 2026
Company plans to submit sBLA for second fill-finish facility later in 2026
Result Drivers
FDA MEETING - Constructive meeting with FDA and Catalent Indiana, no additional corrective actions required, supports BLA resubmission plans
DEBT FACILITY - Secured up to $550 mln in non-dilutive capital to support apitegromab commercialization and pipeline advancement
PIPELINE ADVANCEMENT - Ongoing development of apitegromab for SMA with anticipated U.S. and European launches in 2026
Company press release: ID:nBw1ljMFca
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
FY EPS |
| -$0.88 |
|
FY Net Income |
| -$377.94 mln |
|
FY Income from Operations |
| -$384.65 mln |
|
FY Operating Expenses |
| $384.65 mln |
|
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 16 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"
The average consensus recommendation for the biotechnology & medical research peer group is "buy"
Wall Street's median 12-month price target for Scholar Rock Holding Corp is $50.00, about 15% above its March 2 closing price of $43.48
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
Related Articles
Spot Silver Prices Volatile, Losses Narrow After 7% Plunge, Has Safe-Haven and Industrial Narrative Failed?
TradingKey - During the Asian trading session, spot silver's intraday decline widened to as much as 7%, reaching $83.05/oz, before subsequently narrowing. As of press time, silver was trading at $85.8/oz. Influenced by recent severe tensions in the Middle East and a complex, volatile international landscape, global commodities—particularly pure benzene, liquefied petroleum gas (LPG), ethylene glycol, styrene, and polypropylene—have experienced significant volatility.
Bitcoin Stuck in Range Struggle, Can US-Iran Conflict Help a Breakout?
As the US-Iran conflict continues to escalate, Bitcoin prices remain range-bound and are losing their war premium.
JPMorgan Warns Hormuz Blockade Risks Oil Shutdown in 25 Days, But How Will the US-Iran Conflict Shape Global Oil Prices?
TradingKey - Following the announcement on the night of February 28 banning all vessels from passing through the Strait of Hormuz, JPMorgan Chase issued a warning: if the Strait of Hormuz is completely blocked, the combined onshore and offshore storage capacity of Middle Eastern oil-producing nation
US-Iran Conflict Ignites, Global Arms Race Heats Up, Will Defense Stocks See a New Round of Gains?
TradingKey - On February 28 local time, the United States and Israel launched joint large-scale airstrikes against Iran, targeting its nuclear facilities, missile industry, and naval forces. This marks another sharp escalation in the conflict following the US military strikes on Iranian nuclear facilities in June last year. The military operation not only exacerbates already strained geopolitical tensions but has also sent shockwaves through global capital markets, which is expected to further boost defense stocks.
The Hyperliquid Phenomenon: HYPE Ecosystem’s Path to $250
Explore the Hyperliquid (HYPE) 2026 outlook as it evolves from a high-speed DEX into a powerful Layer 1 ecosystem. This analysis breaks down the $2.95 trillion trading volume, the impact of the HIP-4 prediction market launch, and the HYPE token's technical resilience at the $31.77 level amidst globa
